Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Distillate Capital Fundamental Stability & Value. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
YTD+9.39%
Annualized+13.95%
Positioning StanceCAUTIOUS
Market CapLarge Cap
GeographyUS
Digest Analysis
Quick Take
"Distillate U.S. Fundamental Stability & Value returned 9.39% net YTD through Q3 2026, lagging the S&P 500 as AI mega-caps drove market gains, while the fund maintained a disciplined tilt toward cash-flow-rich, lowly levered companies."
Executive Summary
Distillate Capital's U.S. Fundamental Stability & Value (U.S. FSV) strategy generated a net return of 9.39% year-to-date through the third quarter of 2026, trailing the S&P 500's 12.73% and the Russell 1000 Value's 19.23%. The strategy's underperformance stems from its disciplined avoidance of the top 20 mega-cap artificial intelligence companies, which drove the majority of broad market appreciation despite flat aggregate free cash flows. The portfolio maintains an attractive valuation profile, trading at an 8.0% next-twelve-months free cash flow yield with conservative leverage of 1.1x net debt to EBITDA.
The manager identifies severe systemic risks in the broader market, comparing the current environment to the late 1990s tech bubble. Hyperscaler capital expenditures have reached unprecedented levels as a share of GDP, financed through circular vendor arrangements and heavy debt issuance equivalent to 35% of long-term U.S. Treasury supply. Concurrently, rising global bond yields threaten to trigger severe equity multiple contraction, particularly for highly leveraged firms and speculative growth names that require extraordinary, unproven revenue growth to justify current valuations.
Portfolio activity during the quarterly rebalance reflected systematic rotation into attractively valued, cash-generative businesses with strong balance sheets. New positions were initiated in Lowe's Companies (1.4%), AppLovin (1.3%), and PACCAR (1.0%), while allocations were increased in UnitedHealth Group (to 2.0%) and Booking Holdings (to 1.7%). These additions were funded by complete exits in Abbott Laboratories, Workday, and Global Payments, alongside trims in Salesforce, Accenture, and Merck.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
68%
CautiousHigh
Moderate (68%)
Portfolio positioning is executed through a systematic, rules-based free cash flow and leverage screening methodology rather than discretionary single-stock bets. The strategy demonstrates high process conviction by maintaining minimal exposure to the top 20 AI mega-caps despite significant benchmark tracking pressure. Position weights are distributed methodically across roughly 30 to 50 holdings with top individual allocations capped around 2%.
Growth Outlook
25%
BearishBullish
Bearish (25%)
The letter maintains a cautious market outlook, highlighting that the Buffett Indicator is at record extremes and three-year equity gains have outpaced GDP growth by over six times. Equity free cash flow yields are historically depressed relative to rising fixed income and real estate yields. The manager warns that prevailing index pricing leaves little margin of safety if projected AI revenue growth fails to materialize.
Risk Appetite
35%
DefensiveAggressive
Defensive (35%)
Capital is allocated defensively to protect against rising refinancing costs and multiple compression. The portfolio holds zero allocation to real estate and limits financial sector exposure while completely avoiding highly levered banks. The portfolio maintains an average leverage ratio of 1.1x net debt to EBITDA and an 8.0% free cash flow yield, well above benchmark averages.
Capital Deployment
50%
De-riskingDeploying
Net Neutral (50%)
Capital deployment remains net-neutral and fully invested, governed by regular quarterly rebalance cycles. Capital is recycled efficiently from fully valued exits like Abbott Laboratories and Workday into new holdings such as Lowe's and AppLovin. Cash levels are kept minimal as the mandate calls for full equity exposure within quality-value criteria.
Forward Guidance
50%
CautiousExpansionary
Neutral (50%)
Forward action is focused on continuous disciplined quarterly rebalancing rather than aggressive speculative directional positioning. The manager plans to rotate steadily out of names that have experienced multiple expansion into fundamentally stable, newly cheap cash generators. The strategy explicitly avoids deploying capital into high-multiple AI beneficiaries or indebted companies vulnerable to refinancing shocks.
Language Signal
30%
BearishBullish
Bearish (30%)
The narrative is heavily weighted with cautionary language concerning asset bubbles, circular vendor financing, and unprecedented capital expenditure commitments. Historical parallels to the 1990s tech bust and warnings of equity multiple contraction dominate the macro sections. Constructive language is confined specifically to unloved, attractively valued companies with durable cash flows.
Perceived Risk
85%
Low RiskElevated
Elevated Risk (85%)
Macroeconomic and structural risks are assessed at elevated levels due to the convergence of rising interest rates and extreme market concentration. The manager details specific tail risks including power and construction bottlenecks for data centers, circular vendor financing between AI labs and chipmakers, and equity multiple compression across expensive benchmarks.
Opportunity Density
55%
ScarceAbundant
Selective (55%)
Compelling investments are scarce within the mega-cap momentum and semiconductor sectors due to excessive valuations. However, the manager finds ample opportunity across the remaining 60% of the market that has not participated in the AI frenzy. Attractive cash flow yields remain accessible in select industrials, consumer businesses, and healthcare companies with clean balance sheets.
Time Horizon
75%
Short-TermLong-Term
Decade+ (75%)
The investment framework operates on a multi-year horizon focused on through-cycle cash flow compounding rather than near-term momentum trading. The manager explicitly accepts periods of benchmark tracking error, arguing that fundamental earnings and cash generation are the sole long-term drivers of returns. Valuation mean reversion is expected to unfold over the next three to five years.